Cargando…

High prevalence of COPD in atherosclerosis patients

Atherosclerosis and COPD are both systemic inflammatory diseases that may influence each other. The aim of the present study was to determine the prevalence of COPD in patients with cerebral and/or peripheral artery disease and to assess factors associated with the presence of COPD. Following the di...

Descripción completa

Detalles Bibliográficos
Autores principales: Tuleta, Izabela, Farrag, Tarik, Busse, Laura, Pizarro, Carmen, Schaefer, Christian, Pingel, Simon, Nickenig, Georg, Skowasch, Dirk, Schahab, Nadjib
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5655122/
https://www.ncbi.nlm.nih.gov/pubmed/29089753
http://dx.doi.org/10.2147/COPD.S141988
_version_ 1783273470020288512
author Tuleta, Izabela
Farrag, Tarik
Busse, Laura
Pizarro, Carmen
Schaefer, Christian
Pingel, Simon
Nickenig, Georg
Skowasch, Dirk
Schahab, Nadjib
author_facet Tuleta, Izabela
Farrag, Tarik
Busse, Laura
Pizarro, Carmen
Schaefer, Christian
Pingel, Simon
Nickenig, Georg
Skowasch, Dirk
Schahab, Nadjib
author_sort Tuleta, Izabela
collection PubMed
description Atherosclerosis and COPD are both systemic inflammatory diseases that may influence each other. The aim of the present study was to determine the prevalence of COPD in patients with cerebral and/or peripheral artery disease and to assess factors associated with the presence of COPD. Following the diagnosis of cerebral and/or peripheral artery disease by means of duplex sonography, 166 consecutive patients underwent body plethysmography with capillary blood gas analysis. Thereafter, blood tests with determination of different parameters such as lipid profile, inflammatory and coagulation markers were conducted in remaining 136 patients who fulfilled inclusion criteria of the study. Thirty-six out of 136 patients suffered from COPD, mostly in early stages of the disease. Residual volume indicating emphysema was increased (162.9%±55.9% vs 124.5%±37.0%, p<0.05) and diffusion capacity was decreased (55.1%±19.5% vs 75.3%±18.6%, p<0.05) in COPD patients vs non-COPD group. In capillary blood gas analysis, COPD patients had lower partial pressure of oxygen (70.9±11.5 vs 75.2±11.0 mmHg, p<0.05) and higher partial pressure of carbon dioxide (36.8±7.5 vs 34.4±4.4 mmHg, p<0.05) compared with non-COPD individuals. Presence of COPD was associated with predominance of diabetes mellitus, interleukin-8-related systemic neutrophilic inflammation and anemia. In conclusion, COPD is highly prevalent in patients with atherosclerotic artery disease.
format Online
Article
Text
id pubmed-5655122
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-56551222017-10-31 High prevalence of COPD in atherosclerosis patients Tuleta, Izabela Farrag, Tarik Busse, Laura Pizarro, Carmen Schaefer, Christian Pingel, Simon Nickenig, Georg Skowasch, Dirk Schahab, Nadjib Int J Chron Obstruct Pulmon Dis Original Research Atherosclerosis and COPD are both systemic inflammatory diseases that may influence each other. The aim of the present study was to determine the prevalence of COPD in patients with cerebral and/or peripheral artery disease and to assess factors associated with the presence of COPD. Following the diagnosis of cerebral and/or peripheral artery disease by means of duplex sonography, 166 consecutive patients underwent body plethysmography with capillary blood gas analysis. Thereafter, blood tests with determination of different parameters such as lipid profile, inflammatory and coagulation markers were conducted in remaining 136 patients who fulfilled inclusion criteria of the study. Thirty-six out of 136 patients suffered from COPD, mostly in early stages of the disease. Residual volume indicating emphysema was increased (162.9%±55.9% vs 124.5%±37.0%, p<0.05) and diffusion capacity was decreased (55.1%±19.5% vs 75.3%±18.6%, p<0.05) in COPD patients vs non-COPD group. In capillary blood gas analysis, COPD patients had lower partial pressure of oxygen (70.9±11.5 vs 75.2±11.0 mmHg, p<0.05) and higher partial pressure of carbon dioxide (36.8±7.5 vs 34.4±4.4 mmHg, p<0.05) compared with non-COPD individuals. Presence of COPD was associated with predominance of diabetes mellitus, interleukin-8-related systemic neutrophilic inflammation and anemia. In conclusion, COPD is highly prevalent in patients with atherosclerotic artery disease. Dove Medical Press 2017-10-19 /pmc/articles/PMC5655122/ /pubmed/29089753 http://dx.doi.org/10.2147/COPD.S141988 Text en © 2017 Tuleta et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Tuleta, Izabela
Farrag, Tarik
Busse, Laura
Pizarro, Carmen
Schaefer, Christian
Pingel, Simon
Nickenig, Georg
Skowasch, Dirk
Schahab, Nadjib
High prevalence of COPD in atherosclerosis patients
title High prevalence of COPD in atherosclerosis patients
title_full High prevalence of COPD in atherosclerosis patients
title_fullStr High prevalence of COPD in atherosclerosis patients
title_full_unstemmed High prevalence of COPD in atherosclerosis patients
title_short High prevalence of COPD in atherosclerosis patients
title_sort high prevalence of copd in atherosclerosis patients
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5655122/
https://www.ncbi.nlm.nih.gov/pubmed/29089753
http://dx.doi.org/10.2147/COPD.S141988
work_keys_str_mv AT tuletaizabela highprevalenceofcopdinatherosclerosispatients
AT farragtarik highprevalenceofcopdinatherosclerosispatients
AT busselaura highprevalenceofcopdinatherosclerosispatients
AT pizarrocarmen highprevalenceofcopdinatherosclerosispatients
AT schaeferchristian highprevalenceofcopdinatherosclerosispatients
AT pingelsimon highprevalenceofcopdinatherosclerosispatients
AT nickeniggeorg highprevalenceofcopdinatherosclerosispatients
AT skowaschdirk highprevalenceofcopdinatherosclerosispatients
AT schahabnadjib highprevalenceofcopdinatherosclerosispatients